TOKYO STOCK EXCHANGE-TOKYO PRO MARKET · CHGCY
+2.59% · +$0.5600 · Vol 419.0K
Market closed · last close 4:00 PM ET · price as of 16:01:42 ET
Chugai Pharmaceutical Co Ltd

Chugai Pharmaceutical Co Ltd

Pharmaceuticals
$22.22
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for CHGCY until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is CHGCY moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CHGCY catalysts
About Chugai Pharmaceutical Co Ltd
Pharmaceuticals
Listed since
1956
Country
JP

CHUGAI PHARM UNSP/ADR

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$22.11
Day high
$22.38
Day low
$21.86
Previous close
$21.66
52W high
$33.61
-33.89% from high
52W low
$20.52
13% of range
Market cap
$11.3T
P/E
23.94×
EPS
$286.43
Beta
0.62
Volume
419K
1.56× rel vol
Avg volume
268.2K
VWAP
$22.18
Price history computed in-house
1W
+4.81%
1M
-2.88%
3M
-9.93%
1Y
+8.28%
YTD
-15.42%
SMA 50 $22.70 · below
SMA 200 $25.91 · below
52W position 13%

CHGCY overview

Loading financial statements
Loading CHGCY Form 4 filings
Public disclosures

Congress activity in CHGCY

Federal contracts

CHGCY contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CHGCY in this window.
Lobbying spend

CHGCY lobbying filings, year to date.

Registered lobbying filings matched to Chugai Pharmaceutical Co Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CHGCY in this window.
Loading news for CHGCY
Analyst ratings
Sovereign unlock shows live analyst consensus for CHGCY.
Options
Sovereign unlock shows live options positioning for CHGCY.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.